Table 2.
Ref. | Study period | Country | n | Median follow-up (mo) | Survival | Graft survival | Comments |
Coffin et al[49] | 2001-2007 | United States | 22 | 42 | 85% 1 yr | 85% 1 yr | About 50% had detectable HBV pre transplant |
85% 3 yr | 85% 3 yr | ||||||
Tateo et al[97] | 1999-2007 | France | 13 | 32 | 100% | 100% | 1 co-infected with HDV, 2 with HCV, 4 with HCV and HDV |
Anadol et al[96] | 1997-2011 | Germany | 10 | 611 | 90% 1 yr | NR | |
80% 5 yr | |||||||
Schreibman et al[98] | 1999-2006 | United States | 8 | NR | 75% 1 yr | NR | 2 co-infected with HCV, 1 fulminant hepatic failure |
75% 3 yr | |||||||
Norris et al[99] | 1995-2003 | United Kingdom | 4 | 22 | 100% 1 yr | NR |
For entire series. HBV: Hepatitis B virus; HCV: Hepatitis C virus; NR: Not reported; HDV: Hepatitis D virus.